Skip to main content
. 2017 Apr 4;8(21):34867–34883. doi: 10.18632/oncotarget.16802

Table 1. correlation between miR-509-3-5P expression and clinicopathological parameters in GC (n = 54).

Parameters category No. MiR-509-3-5P expression p
low high
Age 0.055128
< 65 26 17 9
≥ 65 28 11 17
Gender 0.439419
Male 38 21 17
Female 16 7 9
T stage1 0.022088*
T2 5 0 5
T3 21 10 11
T4 28 18 10
N stage N0 11 3 8 0.027214*
N1 12 4 8
N2 13 7 6
N3 18 14 4
UICC stage2 II 17 4 13 0.007740**
III 37 24 13
Nerve invasion Yes 29 17 12 0.283639
No 25 11 14
Vessel invasion Yes 29 14 15 0.571098
No 25 14 11
Differentiation3 High 3 0 3 0.000101***
Moderate 19 4 15
Low 32 24 8
Tumor size ≤ 3 23 12 11 0.967456
> 3 31 16 15

1,2There is no T1 stage tumor or M1 patients in our GC tissues microarray.

3Low differentiation includes poor differentiation, mucinous adenocarcinoma, and signet ring cell carcinoma.

*p < 0.05, **p < 0.01,***p < 0.001.